Using the pre-bronchodilator spirometry curvature to improve estimation of post-bronchodilator airflow obstruction Source: International Congress 2019 – Physiologic assessment of airway diseases Year: 2019
The prevalence of patients with normal post-bronchodilator spirometry that fulfil the criteria for GOLD mild COPD using ECCS predicted equations Source: International Congress 2019 – Respiratory function assessment in disease Year: 2019
Comparison of spirometric z-scores with FEV1 percent prediction in predicting exacerbations in elderly COPD patients Source: International Congress 2016 – In-patient and out-patient COPD management Year: 2016
Within session variability of FEV1 and FVC pre- and post-bronchodilation Source: International Congress 2019 – Quality, performance and interpretation of lung function testing Year: 2019
Distinguishing hyperinflation from combined restriction in patients with reduced FEV1 /FVC and FVC on spirometry Source: Eur Respir J 2006; 28: Suppl. 50, 202s Year: 2006
Comparison of pre and post-bronchodilator single-breath and re-breathe DLCO values amongst healthy, asthmatic and COPD subjects Source: Annual Congress 2013 –New issues in lung function testing Year: 2013
Correlation between spirometric indices (FEV1, FVC) and lung diffusion values (DLCO) in subjects with varying severity of chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2007 - Primary care respiratory problems Year: 2007
Can we use pre-bronchodilator spirometry to define post-bronchodilator airflow obstruction? Source: International Congress 2015 – Epidemiology of respiratory disease Year: 2015
The predictive values of bronchodilator reversibility indicators in asthmatic patients with non-obstructive patterns of spirometry Source: International Congress 2019 – Respiratory function assessment in disease Year: 2019
Changes in spirometry (FVC and FEV1 ) in a closed population of COPD patients using new standarized values for Mexican people Source: Eur Respir J 2003; 22: Suppl. 45, 69s Year: 2003
Spirometric diagnosis of COPD: is postbronchodilator test reliable? Source: Eur Respir J 2006; 28: Suppl. 50, 39s Year: 2006
Comparison of prebronchodilator FEV1/FEV6 of handheld spirometry with postbronchodilator FEV1/FVC of spirometry in Korea: a pilot study Source: International Congress 2017 – Chronic airway disease: markers of disease impact Year: 2017
Patterns of bronchodilator reversibility of FEV1 in asthma and COPD patients Source: Annual Congress 2012 - Translational respiratory medicine in asthma and COPD Year: 2012
Correlation of various parameters with FEV1 in the assessment of asthma severity Source: Eur Respir J 2001; 18: Suppl. 33, 51s Year: 2001
Comparison of spirometric markers of severity and reversibility in patients with asthma and/or COPD in NOVELTY Source: Virtual Congress 2020 – New tools for risk stratification of obstructive diseases Year: 2020
Usefulness of post bronchodilator FVC in the evaluation and spirometric evolution of COPD patients Source: Annual Congress 2013 –Monitoring lung function in airway diseases Year: 2013
FEV6 and FEV1/FEV6 have higher association with small airway function and oxygen saturation than FVC and FEV1/FVC in patients with asthma. Source: Virtual Congress 2020 – Lung function tests and exhaled biomarkers Year: 2020
Repeatability study comparing plethysmographic and spirometric lung function parameters in COPD patients, asthmatics, and healthy subjects Source: Eur Respir J 2006; 28: Suppl. 50, 221s Year: 2006
FEV1/FEV6 versus FEV1/FVC in the spirometric detection of airway obstruction among Asians Source: Annual Congress 2007 - Current issues in airway physiology, pharmacology and monitoring Year: 2007
Correlation of spirometric value to 2D ECHO parameters for diagnosis of pulmonary hypertension in COPD Source: International Congress 2018 – Functional assessment of COPD Year: 2018